Belvedere Trading’s Labcorp LH Stock Holding History

Belvedere Trading’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,235	Closed	-$207K	–	194
2014 Q4	$207K	Buy	+2,235	New	+$197K	﹤0.01%	425

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Belvedere Trading's LH Position: Q1 2015 in Review

Belvedere Trading sold out of Labcorp (LH) in Q1 2015, closing a stake of 2,235 shares — an estimated $207K sold.

Belvedere Trading first reported a position in LH in Q4 2014 and held it in 1 quarter. The position peaked at $207K in Q4 2014. 636 funds tracked by Wall St. Rank hold LH as of Q1 2015.

Belvedere Trading reported no remaining Labcorp position as of Q1 2015 after selling out during the quarter.
Belvedere Trading sold 2,235 Labcorp shares in Q1 2015, an estimated $207K.
Belvedere Trading first reported a position in Labcorp in Q4 2014 and held it in 1 quarter.
Belvedere Trading's Labcorp position peaked at $207K in Q4 2014.
636 funds tracked by Wall St. Rank held Labcorp as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.